| abstract |
Rapamycin analogues of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds are useful in treating neurological disorders or complications due to stroke or head injury; benign or malignant neoplastic disease, carcinomas and adenocarcinomas; proliferative disorders; and inflammatory disorders. The compounds are therefore useful as neuroprotective and neurogenerative, anti-proliferative, and anti-inflammatory agents. (62) Divided Out of 556375 |